New supplement dedicated to skin cancer
July 21, 2022
Synergy Pharm USA can support you from A to Z with the publication of your peer-reviewed journal supplement. We can produce your supplement from conference presentations or your study results. At our health communication agency, several scientific or medical articles can be written in parallel by our medical writers, which allows the rapid publication of the supplement after the event. Our editorial assistance and medical writing team can help to coordinate your project, reducing the delays associated with author proofreading, article review, submission and publication.
We thank the Laboratoires Avène for placing their trust in us to report on the 2021 edition of the “Entretiens d’Avène”. These conferences bring together experts in the field from all over the world and are always a great opportunity to update our knowledge.
The 2021 edition was dedicated to skin cancer, one of the most preventable and treatable types of cancer. However, as skin cancer incidence worldwide continues to rise, continued efforts are needed to improve the effectiveness of prevention and photoprotective measures, and optimize patient diagnosis and care.
The 6 reviews included in the latest supplement issue of “The Journal of the European Academy of Dermatology and Venereology” (JEADV) demonstrate the progress that has been made in recent decades from raising public awareness of skin cancer prevention to innovative advances in photoprotection and early diagnosis, and improved recommendations for patient management.
Find out more from these open access reviews: https://onlinelibrary.wiley.com/toc/14683083/2022/36/S6